(Q48001356)

English

Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome

scientific article published in May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

therapy-related acute myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

0 references

author name string

Steven A Gustafson

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

Pei Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

Su S Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

Lei Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

Lynne V Abruzzo

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

Rajyalakshmi Luthra

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

L Jeffrey Medeiros

7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

Sa A Wang

8

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

language of work or name

1 reference

American Journal of Clinical Pathology

publication date

1 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

American Journal of Clinical Pathology

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

131

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

647-655

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

Associations between morphology, karyotype, and clinical features in myeloid leukemias.

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

The 8;21 translocation in leukemogenesis

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Complex translocation (8;12;21): a new variant of t(8;21) in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients.

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Therapy-related myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Therapy-related myelodysplastic syndrome/acute myeloid leukemia M2 and translocation (8;21).

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Identification and characterization of novel AML1-ETO fusion transcripts in pediatric t(8;21) acute myeloid leukemia: a report from the Children's Oncology Group.

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETO

1 reference

https://api.crossref.org/works/10.1309%2FAJCP5ETHDXO6NCGZ

21 January 2018

Identifiers

10.1309/AJCP5ETHDXO6NCGZ

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19369623

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48001356&oldid=2181253977"